BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jomrich G, Gruber ES, Winkler D, Hollenstein M, Gnant M, Sahora K, Schindl M. Systemic Immune-Inflammation Index (SII) Predicts Poor Survival in Pancreatic Cancer Patients Undergoing Resection. J Gastrointest Surg. 2020;24:610-618. [PMID: 30923999 DOI: 10.1007/s11605-019-04187-z] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 10.7] [Reference Citation Analysis]
Number Citing Articles
1 Murthy P, Boone BA. ASO Author Reflections: Systemic Immune-Inflammation Index (SII) as a Biomarker of Response to Neoadjuvant Therapy in Patients with Pancreatic Adenocarcinoma. Ann Surg Oncol 2020;27:907-8. [PMID: 31823171 DOI: 10.1245/s10434-019-08136-7] [Reference Citation Analysis]
2 Elbeyli A, Kurtul BE. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio levels are associated with keratoconus. Indian J Ophthalmol 2021;69:1725-9. [PMID: 34146015 DOI: 10.4103/ijo.IJO_3011_20] [Reference Citation Analysis]
3 Ozbek E, Besiroglu H, Ozer K, Horsanali MO, Gorgel SN. Systemic immune inflammation index is a promising non-invasive marker for the prognosis of the patients with localized renal cell carcinoma. Int Urol Nephrol 2020;52:1455-63. [DOI: 10.1007/s11255-020-02440-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
4 Gao W, Li M, Zhang Y. Fibrinogen/Albumin Ratio (FAR) in Patients with Triple Negative Breast Cancer and Its Relationship with Epidermal Growth Factor Receptor Expression. Onco Targets Ther 2021;14:5403-15. [PMID: 34908845 DOI: 10.2147/OTT.S339973] [Reference Citation Analysis]
5 Xu J, Hu S, Li S, Wang W, Wu Y, Su Z, Zhou X, Gao Y, Cheng X, Zheng Q. Systemic immune-inflammation index predicts postoperative acute kidney injury in hepatocellular carcinoma patients after hepatectomy. Medicine (Baltimore) 2021;100:e25335. [PMID: 33832108 DOI: 10.1097/MD.0000000000025335] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Esenboğa K, Kurtul A, Yamantürk YY, Akbulut İM, Tutar DE. Comparison of systemic immune-inflammation index levels in patients with isolated coronary artery ectasia versus patients with obstructive coronary artery disease and normal coronary angiogram. Scand J Clin Lab Invest 2022;:1-6. [PMID: 35143364 DOI: 10.1080/00365513.2022.2034034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Shui Y, Li M, Su J, Chen M, Gu X, Guo W. Prognostic and clinicopathological significance of systemic immune-inflammation index in pancreatic cancer: a meta-analysis of 2,365 patients. Aging (Albany NY) 2021;13:20585-97. [PMID: 34435973 DOI: 10.18632/aging.203449] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Pakoz ZB, Ustaoglu M, Vatansever S, Yuksel ES, Topal F, Adani GL. Serum Immune-Inflammation Index Assessment in the Patients with Ulcerative Colitis. Gastroenterology Research and Practice 2022;2022:1-5. [DOI: 10.1155/2022/9987214] [Reference Citation Analysis]
9 Boyuk F. The role of the multi-inflammatory index as a novel inflammation-related index in the differential diagnosis of massive and non-massive pulmonary embolism. Int J Clin Pract 2021;:e14966. [PMID: 34626044 DOI: 10.1111/ijcp.14966] [Reference Citation Analysis]
10 Dong M, Shi Y, Yang J, Zhou Q, Lian Y, Wang D, Ma T, Zhang Y, Mi Y, Gu X, Fan R. Prognostic and clinicopathological significance of systemic immune-inflammation index in colorectal cancer: a meta-analysis. Ther Adv Med Oncol 2020;12:1758835920937425. [PMID: 32699557 DOI: 10.1177/1758835920937425] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
11 Lu L, Feng Y, Liu YH, Tan HY, Dai GH, Liu SQ, Li B, Feng HG. The Systemic Immune-Inflammation Index May Be a Novel and Strong Marker for the Accurate Early Prediction of Acute Kidney Injury in Severe Acute Pancreatitis Patients. J Invest Surg 2021;:1-5. [PMID: 34468253 DOI: 10.1080/08941939.2021.1970864] [Reference Citation Analysis]
12 Dolu AK, Karayiğit O, Ozkan C, Çelik MC, Kalçık M. Relationship between intracoronary thrombus burden and systemic immune-inflammation index in patients with ST-segment elevation myocardial infarction. Acta Cardiol 2022;:1-8. [PMID: 35105281 DOI: 10.1080/00015385.2022.2035082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Casanova N, Diaz-Duran C, Nieto L, Llort C, Elosua R, Clara A. Predictive Value of Complete Blood Count-Derived Inflammatory Markers for 5-Year Survival After Carotid Endarterectomy: Implications for Practice. Angiology 2022;:33197211067581. [PMID: 35089092 DOI: 10.1177/00033197211067581] [Reference Citation Analysis]
14 Lecumberri E, Ruiz-Carmona C, Mateos E, Galarza A, Subirana I, Clara A. Prognostic Value of Inflammatory Biomarkers in 5-Year Survival After Endovascular Repair of Abdominal Aortic Aneurysms in a Predominantly Male Cohort: Implications for Practice. World J Surg 2021;45:1949-55. [PMID: 33721070 DOI: 10.1007/s00268-021-06051-1] [Reference Citation Analysis]
15 Pappalardo A, Giunta EF, Tirino G, Pompella L, Federico P, Daniele B, De Vita F, Petrillo A. Adjuvant Treatment in Pancreatic Cancer: Shaping the Future of the Curative Setting. Front Oncol 2021;11:695627. [PMID: 34485130 DOI: 10.3389/fonc.2021.695627] [Reference Citation Analysis]
16 Liberko M, Kolostova K, Szabo A, Gurlich R, Oliverius M, Soumarova R. Circulating Tumor Cells, Circulating Tumor DNA and Other Blood-based Prognostic Scores in Pancreatic Ductal Adenocarcinoma - Mini-Review. In Vivo 2021;35:31-9. [PMID: 33402447 DOI: 10.21873/invivo.12229] [Reference Citation Analysis]
17 Bittoni A, Pecci F, Mentrasti G, Crocetti S, Lupi A, Lanese A, Pellei C, Ciotti C, Cantini L, Giampieri R, Lenci E, Giglio E, Bini F, Copparoni C, Meletani T, Baleani MG, Berardi R. Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer. Ann Transl Med 2021;9:251. [PMID: 33708878 DOI: 10.21037/atm-20-3499] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Yeter V, Koçak N, Arslan MT, Kan EK. Blood Count-derived Immunoinflammatory Markers in Thyroidassociated Ophthalmopathy. Korean J Ophthalmol 2021;35:198-206. [PMID: 34120418 DOI: 10.3341/kjo.2021.0012] [Reference Citation Analysis]
19 Mori R, Matsuyama R, Taniguchi K, Goto K, Miyake K, Hiratani S, Homma Y, Ohta Y, Kumamoto T, Morioka D, Endo I. Efficacy of prolonged elemental diet therapy after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: A pilot prospective randomized trial (UMIN000004108). Clin Nutr ESPEN 2019;34:116-24. [PMID: 31677701 DOI: 10.1016/j.clnesp.2019.07.017] [Reference Citation Analysis]
20 Zhang YY, Li WQ, Li ZF, Guo XH, Zhou SK, Lin A, Yan WH. Higher Levels of Pre-operative Peripheral Lymphocyte Count Is a Favorable Prognostic Factor for Patients With Stage I and II Rectal Cancer. Front Oncol 2019;9:960. [PMID: 31612109 DOI: 10.3389/fonc.2019.00960] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
21 Jomrich G, Wilfing L, Radosavljevic S, Parak A, Winkler D, Timelthaler G, Schindl M, Schoppmann SF, Klösch B. Fibroblast growth factor 8 overexpression is predictive of poor prognosis in pancreatic ductal adenocarcinoma. Eur Surg 2020;52:282-9. [DOI: 10.1007/s10353-020-00669-6] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Huang J, Zhang Q, Wang R, Ji H, Chen Y, Quan X, Zhang C. Systemic Immune-Inflammatory Index Predicts Clinical Outcomes for Elderly Patients with Acute Myocardial Infarction Receiving Percutaneous Coronary Intervention. Med Sci Monit 2019;25:9690-701. [PMID: 31849367 DOI: 10.12659/MSM.919802] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
23 Wei Y, Wang Y, Li H, Wang C, Liu S, Huang Z, Wang G, Tao Y, Xia Y. A Nomogram to Predict Survival in Patients With Locoregional Recurrent Nasopharyngeal Carcinoma Receiving Comprehensive Treatment. Front Oncol 2022;12:892510. [DOI: 10.3389/fonc.2022.892510] [Reference Citation Analysis]
24 Li X, Lin H, Ouyang R, Yang Y, Peng J. Prognostic significance of the systemic immune-inflammation index in pancreatic carcinoma patients: A meta-analysis. Biosci Rep 2021:BSR20204401. [PMID: 34286342 DOI: 10.1042/BSR20204401] [Reference Citation Analysis]
25 Nalbant A, Demirci T, Kaya T, Aydın A, Altındiş M, Güçlü E. Can prognostic nutritional index and systemic immune-inflammatory index predict disease severity in COVID-19? Int J Clin Pract 2021;:e14544. [PMID: 34137143 DOI: 10.1111/ijcp.14544] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Conte M, Martucci M, Mosconi G, Chiariello A, Cappuccilli M, Totti V, Santoro A, Franceschi C, Salvioli S. GDF15 Plasma Level Is Inversely Associated With Level of Physical Activity and Correlates With Markers of Inflammation and Muscle Weakness. Front Immunol 2020;11:915. [PMID: 32477368 DOI: 10.3389/fimmu.2020.00915] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
27 Topkan E, Selek U, Pehlivan B, Kucuk A, Haksoyler V, Kilic Durankus N, Sezen D, Bolukbasi Y. The Prognostic Significance of Novel Pancreas Cancer Prognostic Index in Unresectable Locally Advanced Pancreas Cancers Treated with Definitive Concurrent Chemoradiotherapy. J Inflamm Res 2021;14:4433-44. [PMID: 34511977 DOI: 10.2147/JIR.S329611] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Sun L, Jin Y, Hu W, Zhang M, Jin B, Xu H, Du S, Xu Y, Zhao H, Lu X, Sang X, Zhong S, Yang H, Mao Y. The Impacts of Systemic Immune-Inflammation Index on Clinical Outcomes in Gallbladder Carcinoma. Front Oncol 2020;10:554521. [PMID: 33194617 DOI: 10.3389/fonc.2020.554521] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Lu Z, Yan W, Liang J, Yu M, Liu J, Hao J, Wan Q, Liu J, Luo C, Chen Y. Nomogram Based on Systemic Immune-Inflammation Index to Predict Survival of Tongue Cancer Patients Who Underwent Cervical Dissection. Front Oncol 2020;10:341. [PMID: 32219070 DOI: 10.3389/fonc.2020.00341] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
30 Kimura N, Yamada S, Takami H, Murotani K, Yoshioka I, Shibuya K, Sonohara F, Hoshino Y, Hirano K, Watanabe T, Baba H, Mori K, Miwa T, Kanda M, Hayashi M, Matsui K, Okumura T, Kodera Y, Fujii T. Optimal Preoperative Multidisciplinary Treatment in Borderline Resectable Pancreatic Cancer. Cancers (Basel) 2020;13:E36. [PMID: 33374369 DOI: 10.3390/cancers13010036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
31 Elbeyli A, Kurtul BE, Ozcan DO, Ozcan SC, Dogan E. Assessment of Red Cell Distribution Width, Platelet/lymphocyte Ratio, Systemic Immune-inflammation Index, and Neutrophil/lymphocyte Ratio Values in Patients with Central Retinal Artery Occlusion. Ocul Immunol Inflamm 2021;:1-5. [PMID: 34524949 DOI: 10.1080/09273948.2021.1976219] [Reference Citation Analysis]
32 Gok M, Kurtul A. A novel marker for predicting severity of acute pulmonary embolism: systemic immune-inflammation index. Scandinavian Cardiovascular Journal 2021;55:91-6. [DOI: 10.1080/14017431.2020.1846774] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
33 Nissani A, Lev-Ari S, Meirson T, Jacoby E, Asher N, Ben-Betzalel G, Itzhaki O, Shapira-Frommer R, Schachter J, Markel G, Besser MJ. Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapy. J Immunother Cancer 2021;9:e001743. [PMID: 33990415 DOI: 10.1136/jitc-2020-001743] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Wang Z, Zhang J, Luo S, Zhao X. Prognostic Significance of Systemic Immune-Inflammation Index in Patients With Diffuse Large B-Cell Lymphoma. Front Oncol 2021;11:655259. [PMID: 34123808 DOI: 10.3389/fonc.2021.655259] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Elbeyli A, Kurtul BE, Ozcan SC, Ozarslan Ozcan D. The diagnostic value of systemic immune-inflammation index in diabetic macular oedema. Clin Exp Optom 2021;:1-5. [PMID: 34763621 DOI: 10.1080/08164622.2021.1994337] [Reference Citation Analysis]
36 Schlanger D, Popa C, Pașca S, Seicean A, Al Hajjar N. The role of systemic immuno-inflammatory factors in resectable pancreatic adenocarcinoma: a cohort retrospective study. World J Surg Oncol 2022;20:144. [PMID: 35513845 DOI: 10.1186/s12957-022-02606-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Yang J, Bao Y, Chen W, Duan Y, Sun D. Nomogram Based on Systemic Immune Inflammation Index and Prognostic Nutrition Index Predicts Recurrence of Hepatocellular Carcinoma After Surgery. Front Oncol 2020;10:551668. [PMID: 33163397 DOI: 10.3389/fonc.2020.551668] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Ozarslan Ozcan D, Kurtul BE, Ozcan SC, Elbeyli A. Increased Systemic Immune-Inflammation Index Levels in Patients with Dry Eye Disease. Ocul Immunol Inflamm 2020;:1-5. [PMID: 32990489 DOI: 10.1080/09273948.2020.1821899] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
39 Shang J, Han X, Zha H, Tao H, Li X, Yuan F, Chen G, Wang L, Ma J, Hu Y. Systemic Immune-Inflammation Index and Changes of Neutrophil-Lymphocyte Ratio as Prognostic Biomarkers for Patients With Pancreatic Cancer Treated With Immune Checkpoint Blockade. Front Oncol 2021;11:585271. [PMID: 33718140 DOI: 10.3389/fonc.2021.585271] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
40 Murthy P, Zenati MS, Al Abbas AI, Rieser CJ, Bahary N, Lotze MT, Zeh HJ 3rd, Zureikat AH, Boone BA. Prognostic Value of the Systemic Immune-Inflammation Index (SII) After Neoadjuvant Therapy for Patients with Resected Pancreatic Cancer. Ann Surg Oncol 2020;27:898-906. [PMID: 31792715 DOI: 10.1245/s10434-019-08094-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
41 Li H, Wang JJ, Zhang M, Ren B, Li JX, Xu L, Wu H. Prognostic significance of systemic immune-inflammation index in patients with intrahepatic cholangiocarcinoma undergoing hepatic resection. World J Gastrointest Oncol 2020; 12(4): 467-482 [PMID: 32368324 DOI: 10.4251/wjgo.v12.i4.467] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
42 Wang D, Hu X, Xiao L, Long G, Yao L, Wang Z, Zhou L. Prognostic Nutritional Index and Systemic Immune-Inflammation Index Predict the Prognosis of Patients with HCC. J Gastrointest Surg 2021;25:421-7. [PMID: 32026332 DOI: 10.1007/s11605-019-04492-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
43 Toyoda J, Sahara K, Maithel SK, Abbott DE, Poultsides GA, Wolfgang C, Fields RC, He J, Scoggins C, Idrees K, Shen P, Endo I, Pawlik TM. Prognostic Utility of Systemic Immune-Inflammation Index After Resection of Extrahepatic Cholangiocarcinoma: Results from the U.S. Extrahepatic Biliary Malignancy Consortium. Ann Surg Oncol 2022. [PMID: 35768667 DOI: 10.1245/s10434-022-12058-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Aziz MH, van Dongen JC, Saida L, Suker M, van Vugt JLA, van Putten Y, Sideras K, Groen JV, Mieog JSD, Lucassen CJ, Droop A, Mauff K, Shahbazi Feshtali S, Groot Koerkamp B, Mustafa DAM, van Eijck CJ. High Systemic Immune Inflammation Index Is Associated With Low Skeletal Muscle Quantity in Resectable Pancreatic Ductal Adenocarcinoma. Front Oncol 2022;12:827755. [PMID: 35296013 DOI: 10.3389/fonc.2022.827755] [Reference Citation Analysis]
45 Hata T, Mizuma M, Motoi F, Ishida M, Morikawa T, Nakagawa K, Hayashi H, Kanno A, Masamune A, Kamei T, Naitoh T, Furukawa T, Unno M. An integrated analysis of host- and tumor-derived markers for predicting high-grade dysplasia and associated invasive carcinoma of intraductal papillary mucinous neoplasms of the pancreas. Surg Today 2020;50:1039-48. [PMID: 32124086 DOI: 10.1007/s00595-020-01982-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
46 Qi C, Zhou Y, Hu Z, Niu H, Yue F, An H, Chen Z, Wang P, Wang L, Duan G. The prognostic value of the advanced lung cancer inflammation index (ALI) for patients with neuroblastoma. J Int Med Res 2022;50:3000605221109382. [PMID: 35770522 DOI: 10.1177/03000605221109382] [Reference Citation Analysis]
47 Özata Gündoğdu K, Doğan E, Çelik E, Alagöz G. Serum inflammatory marker levels in serous macular detachment secondary to diabetic macular edema. Eur J Ophthalmol 2022;:11206721221083465. [PMID: 35225038 DOI: 10.1177/11206721221083465] [Reference Citation Analysis]
48 Hung SP, Chen PR, Ho TY, Chang KP, Chou WC, Lee CH, Wu YY, Chen PJ, Lin CH, Chou YC, Fan KH, Lin CY, Huang BS, Tung-Chieh Chang J, Wang CC, Tsang NM. Prognostic significance of the preoperative systemic immune-inflammation index in patients with oral cavity squamous cell carcinoma treated with curative surgery and adjuvant therapy. Cancer Med 2021;10:649-58. [PMID: 33325655 DOI: 10.1002/cam4.3650] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
49 Taniai T, Haruki K, Furukawa K, Onda S, Yasuda J, Shirai Y, Gocho T, Yanagaki M, Hamura R, Shiba H, Ikegami T. The novel index using preoperative C-reactive protein and neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with pancreatic cancer. Int J Clin Oncol 2021. [PMID: 34110531 DOI: 10.1007/s10147-021-01964-2] [Reference Citation Analysis]
50 Shimizu Y, Ashida R, Sugiura T, Okamura Y, Ito T, Yamamoto Y, Ohgi K, Otsuka S, Notsu A, Uesaka K. Prognostic Impact of Indicators of Systemic Inflammation and the Nutritional Status of Patients with Resected Carcinoma of the Ampulla of Vater: A Single-Center Retrospective Study. World J Surg 2021. [PMID: 34661701 DOI: 10.1007/s00268-021-06346-3] [Reference Citation Analysis]